MOTS logo

Motus GI Holdings (MOTS) Company Overview

Profile

Full Name:

Motus GI Holdings, Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 14, 2018

Indexes:

Not included

Description:

Motus GI Holdings focuses on developing innovative medical devices for gastrointestinal procedures. Their main product, the Motus GI system, helps doctors perform endoscopic procedures more effectively, improving patient outcomes and safety. The company aims to enhance the efficiency of digestive health treatments.

Key Details

Price

$0.00

Annual Revenue

$319.00 K(-46.11% YoY)

Annual EPS

-$15.89(+81.56% YoY)

Annual ROE

-454.34%

Beta

0.43

Events Calendar

Earnings

Next earnings date:

Feb 11, 2025

Recent quarterly earnings:

May 14, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 2, 2023

Analyst ratings

Recent major analysts updates

Sep 27, 23 HC Wainwright & Co.
Buy
Aug 16, 23 HC Wainwright & Co.
Buy
Jun 15, 23 HC Wainwright & Co.
Buy
Nov 15, 22 Piper Sandler
Overweight
Nov 15, 22 HC Wainwright & Co.
Buy
Aug 15, 22 HC Wainwright & Co.
Buy
Jul 26, 22 HC Wainwright & Co.
Buy
May 16, 22 HC Wainwright & Co.
Buy
Nov 16, 20 HC Wainwright & Co.
Buy
Apr 21, 20 H.C. Wainwright
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Why Is Motus GI (MOTS) Stock Down 37% Today?
Why Is Motus GI (MOTS) Stock Down 37% Today?
Why Is Motus GI (MOTS) Stock Down 37% Today?
MOTS
InvestorPlaceApril 12, 2024

Motus GI stock is declining on Friday after receiving a delisting warning from the Nasdaq Exchange on April 5.

Why Is Motus GI (MOTS) Stock Down 44% Today?
Why Is Motus GI (MOTS) Stock Down 44% Today?
Why Is Motus GI (MOTS) Stock Down 44% Today?
MOTS
InvestorPlaceDecember 19, 2023

Motus GI (NASDAQ: MOTS ) stock is falling on Tuesday after the medical technology company announced the pricing of its shares in a public offering. This has the company offering 3,333,334 shares of MOTS stock for $1.50 per share.

Why Is Motus GI (MOTS) Stock Down Today?
Why Is Motus GI (MOTS) Stock Down Today?
Why Is Motus GI (MOTS) Stock Down Today?
MOTS
InvestorPlaceMay 19, 2023

Motus GI (NASDAQ: MOTS ) stock is slipping on Friday after the medical technology company announced a private placement. This has Motus GI offering 4,142,012 shares of MOTS stock for $0.845 each.

Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
MOTS
Zacks Investment ResearchMay 10, 2023

Motus GI Holdings, Inc. (MOTS) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.80 per share a year ago.

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
MOTS
Zacks Investment ResearchMarch 31, 2023

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FAQ

  • What is the ticker symbol for Motus GI Holdings?
  • Does Motus GI Holdings pay dividends?
  • What sector is Motus GI Holdings in?
  • What industry is Motus GI Holdings in?
  • What country is Motus GI Holdings based in?
  • When did Motus GI Holdings go public?
  • Is Motus GI Holdings in the S&P 500?
  • Is Motus GI Holdings in the NASDAQ 100?
  • Is Motus GI Holdings in the Dow Jones?
  • When was Motus GI Holdings's last earnings report?
  • When does Motus GI Holdings report earnings?
  • Should I buy Motus GI Holdings stock now?

What is the ticker symbol for Motus GI Holdings?

The ticker symbol for Motus GI Holdings is NASDAQ:MOTS

Does Motus GI Holdings pay dividends?

No, Motus GI Holdings does not pay dividends

What sector is Motus GI Holdings in?

Motus GI Holdings is in the Healthcare sector

What industry is Motus GI Holdings in?

Motus GI Holdings is in the Medical Devices industry

What country is Motus GI Holdings based in?

Motus GI Holdings is headquartered in United States

When did Motus GI Holdings go public?

Motus GI Holdings's initial public offering (IPO) was on February 14, 2018

Is Motus GI Holdings in the S&P 500?

No, Motus GI Holdings is not included in the S&P 500 index

Is Motus GI Holdings in the NASDAQ 100?

No, Motus GI Holdings is not included in the NASDAQ 100 index

Is Motus GI Holdings in the Dow Jones?

No, Motus GI Holdings is not included in the Dow Jones index

When was Motus GI Holdings's last earnings report?

Motus GI Holdings's most recent earnings report was on May 14, 2024

When does Motus GI Holdings report earnings?

The next expected earnings date for Motus GI Holdings is Feb 11, 2025

Should I buy Motus GI Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions